ArticleFrontiers in immunology2026
What affects natural killer cell activity: a cross-sectional study.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Natural killer (NK) cells are key effectors of innate immunity, mediating rapid defense against infections and malignancies while maintaining tissue homeostasis. Despite its clinical relevance, few large-scale studies have comprehensively analyzed the diverse factors influencing NK cell activity (NKA). Methods: This study analyzed factors associated with NKA in 11,007 health-screening records integrating clinical, hematologic, metabolic, inflammatory, lifestyle, and self-reported symptom data. Results: 46 check-up variables and 14 questionnaire items were significantly associated with NKA, including inflammatory markers such as neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), platelet count, and monocyte count; metabolic indices including albumin, total protein, alkaline phosphatase (ALP), low-density lipoprotein (LDL)-cholesterol, calcium, and phosphorus; tumor markers such as carcinoembryonic antigen (CEA); lifestyle factors including smoking, exercise, and sleep quality; and subjective symptoms such as fatigue, dizziness, nocturia, myalgia, and heat intolerance. Artificial intelligence models captured nonlinear interactions among heterogeneous variables, achieving the highest area under the receiver operating characteristic curve of 0.716 ± 0.014 for identifying low-NKA individuals. SHAP analysis identified neutrophil count, PLR, and platelet count as top predictors. Discussion: Lower NKA was associated with elevated inflammatory markers and altered metabolic profiles, highlighting the interplay between systemic inflammation, metabolic dysregulation, and innate immune function. This study provides the first integrated, population-scale mapping of NKA association from routine health checkup data, demonstrating the feasibility of AI-driven immune profiling.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.